Scientific Approach

Business Development

"Tmunity is actively exploring a variety of innovative models for collaboration with third parties that will enhance our existing product pipeline and support the development of next-generation CAR-T and TCR therapies, establish revenue-generating projects in certain therapeutic areas and target programs, or complement our core discovery and manufacturing capabilities. With any of these opportunities, the unparalleled expertise we offer provides a unique enabling environment for partners with novel technologies and methods in cell or gene therapy."

Michael Christiano

Tmunity is pursuing a selective and targeted business development and licensing strategy to further enhance its ability to integrate the latest science, medicine and technology toward the creation and delivery of best-in-class cell therapies for patients with unmet medical needs.


We welcome inquiries on working with Tmunity.